Financial Daily from THE HINDU group of publications
Friday, Nov 29, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Standards & Benchmarks


JB Chem gets EU certification for 2 drugs

Our Bureau

NEW DELHI, Nov. 28

THE Rs 276-crore J.B. Chemicals & Pharmaceuticals Ltd (JBCPL), one of the domestic mid-cap pharmaceutical companies and the flagship of the Unique Group, has obtained the `Certificate of Suitability to European Pharmacopoeia Monograph' or `EP4' from the European Union (EU) for its active pharmaceutical ingredients (API) - Metronidazole and Diclofenac Sodium.

Metronidazole is currently being exported to the US, Germany, Italy, the Netherlands and Iran and sales during 2001-02 amounted to about Rs 7 crore. The company's Metronidazole manufacturing plant at Ankleshwar (Gujarat) already has US FDA and TGA Australia approval.

Exports of Diclofenac Sodium, on the other hand, constituted about 39 per cent of the drug's sales of Rs 18 crore and seven per cent of JBCPL's total sales amounting to Rs 276 crore during the same year.

JBCPL currently exports Diclofenac Sodium to Germany, Mexico, Italy and Iran.

Send this article to Friends by E-Mail
Comment on this article to BLFeedback@thehindu.co.in

Stories in this Section
Goa next in list for Sun-n-Sand — Pune operations commence


Organon (India) to shift operations to Mumbai
M.L. Narula to take over as MD of ACC
Ranbaxy to provide AIDS drugs to 10 lakh patients
SAB India changes name
One Alliance hikes rates
Accounting standards panel being reconstituted
Tribunal rejects Grasim appeal
Grasim still confident
Final report on biotech cancer drug shortly
Madras HC stays action by Indian Bank
No more VRS for TN NTC staff: Official
NTC asset sale draws lukewarm response
HLL pays Rs 44 cr for remaining 26 pc in Modern Foods
Opposition to Saurashtra Cements unit intensifies
Himalaya Drug plans new venture in Egypt
JB Chem gets EU certification for 2 drugs
BIFR pulls up IDBI in Binny case
BIFR may decide on ECL soon
Valvoline Cummins targets 35% growth in turnover
Borland to double tech, sales team — Aims at 30 pc growth this fiscal
Jet CEO says he's quitting to go back home


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line